Christopher Boudakian, DO
Spinal Cord Injury Medicine · Los Angeles, CANPI 1396005849
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,776 of the $3,824 with a category attached, or 72.6%. 11 manufacturers reported payments, led by Medtronic at 55.6% of the total.
Across 70 payments — averaging $54.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Ipsen Biopharmaceuticals, Inc$477
- Amgen$354
- Johnson & Johnson$157
- Coloplast$150
- Amneal Pharmaceuticals LLC$132
- plus $427 from 5 others
What the payments were for
- Travel & lodging$97425%
- Food & beverage$2,77673%
- Education$150%
- Gifts$602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 25 | $2,127 |
| Ipsen Biopharmaceuticals, Inc | 17 | $477 |
| Amgen | 3 | $354 |
| Johnson & Johnson | 3 | $157 |
| Coloplast | 3 | $150 |
| Amneal Pharmaceuticals LLC | 6 | $132 |
| Saol Therapeutics Inc. | 4 | $117 |
| Merck | 1 | $111 |
| AbbVie(2 entities) | 4 | $91 |
| ABC Home Medical Supply, Inc. | 3 | $80 |
| Microtransponder, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$649
- LIORESAL$598
- SPEEDICATH$134
- INTELLIS$132
- Prolia$123
- EVENITY$120
- ZERBAXA$111
- Repatha$111
- XARELTO$111
How this compares
Too few spinal cord injury medicine providers in Californiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $12,862 |
| Naloxone Hcl | 35 | $2,146 |
| Baclofen | 30 | $1,586 |
| Pregabalin | 17 | $702 |
| Gabapentin | 36 | $655 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $308 |
| Tizanidine Hcl | 17 | $308 |
| Pantoprazole Sodium | 25 | $147 |
| Amlodipine Besylate | 13 | $95 |
| Cyclobenzaprine Hcl | 14 | $69 |
| Atorvastatin Calcium | 18 | $67 |
| Tamsulosin Hcl | 14 | $60 |
Paid to pharmacies, not to this prescriber.
Other spinal cord injury medicine in Los Angeles
- Robert SibleyLos Angeles$26
- Edward LeroyFresno$12K
- Valerie Chavez-AromOrange$5K
- Ramin HazanyInglewood$2K
- Patricia NanceLong Beach$1K
- Jeremy LouParamount$581
- Muhammad AkbarClovis$192
- Vernon LinLong Beach$189
- Inder PerkashStanford$153
- Shane StoneSacramento$141
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.